Literature DB >> 17502399

Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.

Jennifer M Taylor1, Melanie E Ziman, Julie Fong, Jay V Solnick, Michael Vajdy.   

Abstract

The ability to induce long-term immunity to Helicobacter pylori is necessary for an effective vaccine. This study was designed to establish the most efficient route(s) (systemic, mucosal, or a combination) of immunization for induction of long-term immunity and to define correlates of protection. Mice were immunized orally alone (oral group), intramuscularly (i.m.) alone (i.m. group), orally followed by i.m. (oral/i.m. group), or i.m. followed by orally (i.m./oral group). Long-term protective immunity to oral H. pylori challenge was observed 3 months after immunization through the i.m. or oral/i.m. route. Protection correlated with an increase in H. pylori-specific interleukin-12 and both immunoglobulin G1 (IgG1) and IgG2a serum titers following challenge. Mice that were not protected (oral or i.m./oral) had increased levels of IgA in both sera and Peyer's patches. This study demonstrates the ability to induce long-term immunity against H. pylori, provides correlates of protection, and illustrates the crucial role of the immunization route(s).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502399      PMCID: PMC1932914          DOI: 10.1128/IAI.01470-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 2.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 3.  The design of vaccines against Helicobacter pylori and their development.

Authors:  G Del Giudice; A Covacci; J L Telford; C Montecucco; R Rappuoli
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.

Authors:  Ali A Akhiani; Jacques Pappo; Zita Kabok; Karin Schön; Wei Gao; Lennart E Franzén; Nils Lycke
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

5.  Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin.

Authors:  N Lycke; J Holmgren
Journal:  Scand J Immunol       Date:  1986-05       Impact factor: 3.487

6.  Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study.

Authors:  P Sutton; S J Danon; M Walker; L J Thompson; J Wilson; T Kosaka; A Lee
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 7.  Reinfection versus recrudescence in Helicobacter pylori infection.

Authors:  A van der Ende; R W van der Hulst; J Dankert; G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

8.  Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.

Authors:  Michael J McCluskie; Risini D Weeratna; Paul J Payette; Heather L Davis
Journal:  FEMS Immunol Med Microbiol       Date:  2002-02-18

Review 9.  Experience with registered mucosal vaccines.

Authors:  Guido Dietrich; Monika Griot-Wenk; Ian C Metcalfe; Alois B Lang; Jean-François Viret
Journal:  Vaccine       Date:  2003-01-30       Impact factor: 3.641

10.  Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice.

Authors:  Christine A Garhart; Raymond W Redline; John G Nedrud; Steven J Czinn
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  8 in total

1.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

2.  Surreptitious manipulation of the human host by Helicobacter pylori.

Authors:  Dawn A Israel; Richard M Peek
Journal:  Gut Microbes       Date:  2010-03

Review 3.  Helicobacter pylori vaccination: is there a path to protection?

Authors:  Florian Anderl; Markus Gerhard
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Stromal regulation of human gastric dendritic cells restricts the Th1 response to Helicobacter pylori.

Authors:  Diane Bimczok; Jayleen M Grams; Richard D Stahl; Ken B Waites; Lesley E Smythies; Phillip D Smith
Journal:  Gastroenterology       Date:  2011-06-12       Impact factor: 22.682

5.  Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity.

Authors:  Karen J Fairlie-Clarke; Tracey J Lamb; Jean Langhorne; Andrea L Graham; Judith E Allen
Journal:  BMC Immunol       Date:  2010-02-17       Impact factor: 3.615

6.  The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction.

Authors:  Lanfen Chen; Zhangguo Chen; Kristi Baker; Elizabeth M Halvorsen; Andre Pires da Cunha; Magdalena B Flak; Georg Gerber; Yu-Hwa Huang; Shuhei Hosomi; Janelle C Arthur; Ken J Dery; Takashi Nagaishi; Nicole Beauchemin; Kathryn V Holmes; Joshua W K Ho; John E Shively; Christian Jobin; Andrew B Onderdonk; Lynn Bry; Howard L Weiner; Darren E Higgins; Richard S Blumberg
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

7.  Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.

Authors:  Fengmin Zhou; Amanda Goodsell; Yasushi Uematsu; Michael Vajdy
Journal:  Clin Vaccine Immunol       Date:  2009-02-04

8.  Optimising the quantification of cytokines present at low concentrations in small human mucosal tissue samples using Luminex assays.

Authors:  Emily Staples; Richard James Michael Ingram; John Christopher Atherton; Karen Robinson
Journal:  J Immunol Methods       Date:  2013-05-01       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.